Your browser doesn't support javascript.
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.
Peña-Silva, Ricardo; Duffull, Stephen B; Steer, Andrew C; Jaramillo-Rincon, Sandra X; Gwee, Amanda; Zhu, Xiao.
  • Peña-Silva R; School of Medicine, Universidad de los Andes, Bogotá, Colombia.
  • Duffull SB; Lown Scholars Program, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Steer AC; Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand.
  • Jaramillo-Rincon SX; Department of General Medicine, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.
  • Gwee A; Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • Zhu X; Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Br J Clin Pharmacol ; 87(3): 1589-1590, 2021 03.
Article in English | MEDLINE | ID: covidwho-687425
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / Drug Repositioning / COVID-19 Drug Treatment / Antiparasitic Agents Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Bcp.14476

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / Drug Repositioning / COVID-19 Drug Treatment / Antiparasitic Agents Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Bcp.14476